• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用高效液相色谱-紫外系统测定活性药物成分中潜在的基因毒性杂质5-氨基-2-氯吡啶。

Determination of Potential Genotoxic Impurity, 5-Amino-2-Chloropyridine, in Active Pharmaceutical Ingredient Using the HPLC-UV System.

作者信息

Soyseven Murat, Keçili Rüstem, Aboul-Enein Hassan Y, Arli Göksel

机构信息

Department of Medical Services and Techniques, Yunus Emre Vocational School of Health Services, Anadolu University, Eskişehir 26470, Turkey.

Department of Pharmacy, Program in Pharmacy Services, Yunus Emre Vocational School of Health Services, Anadolu University, Eskişehir 26470, Turkey.

出版信息

J Chromatogr Sci. 2021 Feb 15;59(3):241-245. doi: 10.1093/chromsci/bmaa100.

DOI:10.1093/chromsci/bmaa100
PMID:33236069
Abstract

A novel analytical method, based on high-performance liquid chromatography with a UV (HPLC-UV) detection system for the sensitive detection of a genotoxic impurity (GTI) 5-amino-2-chloropyridine (5A2Cl) in a model active pharmaceutical ingredient (API) tenoxicam (TNX), has been developed and validated. The HPLC-UV method was used for the determination of GTI 5A2Cl in API TNX. The compounds were separated using a mobile phase composed of water (pH 3 adjusted with orthophosphoric acid): MeOH, (50:50: v/v) on a C18 column (150 × 4.6 mm i.d., 2.7 μm) at a flow rate of 0.7 mL min-1. Detection was carried out in the 254 nm wavelength. Column temperature was maintained at 40°C during the analyses and 10 μL volume was injected into the HPLC-UV system. The method was validated in the range of 1-40 μg mL-1. The obtained calibration curves for the GTI compound was found linear with equation, y = 40766x - 1125,6 (R2 = 0.999). The developed analytical method toward the target compounds was accurate, and the achieved limit of detection and limit of quantification values for the target compound 5A2Cl were 0.015 and 0.048 μg mL-1, respectively. The recovery values were calculated and found to be between 98.80 and 100.03%. The developed RP-HPLC-UV analytical method in this research is accurate, precise, rapid, simple and appropriate for the sensitive analysis of target GTI 5A2Cl in model API TNX.

摘要

已开发并验证了一种基于高效液相色谱-紫外(HPLC-UV)检测系统的新型分析方法,用于灵敏检测模型活性药物成分(API)替诺昔康(TNX)中的遗传毒性杂质(GTI)5-氨基-2-氯吡啶(5A2Cl)。HPLC-UV方法用于测定API替诺昔康中的GTI 5A2Cl。使用由水(用正磷酸调节pH至3):甲醇(50:50,v/v)组成的流动相,在C18柱(内径150×4.6 mm,粒径2.7μm)上以0.7 mL min-1的流速分离化合物。在254 nm波长处进行检测。分析过程中柱温保持在40°C,将10μL体积的样品注入HPLC-UV系统。该方法在1-40μg mL-1范围内进行了验证。发现GTI化合物的校准曲线呈线性,方程为y = 40766x - 1125.6(R2 = 0.999)。所开发的针对目标化合物的分析方法准确,目标化合物5A2Cl的检测限和定量限分别为0.015和0.048μg mL-1。计算回收率,发现回收率在98.80%至100.03%之间。本研究中开发的RP-HPLC-UV分析方法准确、精密、快速、简单,适用于模型API替诺昔康中目标GTI 5A2Cl的灵敏分析。

相似文献

1
Determination of Potential Genotoxic Impurity, 5-Amino-2-Chloropyridine, in Active Pharmaceutical Ingredient Using the HPLC-UV System.使用高效液相色谱-紫外系统测定活性药物成分中潜在的基因毒性杂质5-氨基-2-氯吡啶。
J Chromatogr Sci. 2021 Feb 15;59(3):241-245. doi: 10.1093/chromsci/bmaa100.
2
Quantitative determination of potential genotoxic impurity 3-aminopyridine in linagliptin active pharmaceutical ingredient using HILIC-UV.采用亲水作用色谱-紫外检测法定量测定利格列汀原料药中潜在遗传毒性杂质 3-氨基吡啶。
Biomed Chromatogr. 2020 Nov;34(11):e4930. doi: 10.1002/bmc.4930. Epub 2020 Jul 23.
3
Method development and validation study for quantitative determination of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride a genotoxic impurity in pantoprazole active pharmaceutical ingredient (API) by LC/MS/MS.建立并验证了 LC/MS/MS 法用于定量测定泮托拉唑原料药中基因毒性杂质 2-氯甲基-3,4-二甲氧基吡啶盐酸盐。
J Pharm Biomed Anal. 2012 Nov;70:592-7. doi: 10.1016/j.jpba.2012.05.031. Epub 2012 Jun 5.
4
A simple and sensitive method to analyze genotoxic impurity hydrazine in pharmaceutical materials.一种分析药物原料中基因毒性杂质肼的简单灵敏方法。
J Pharm Biomed Anal. 2016 Jul 15;126:141-7. doi: 10.1016/j.jpba.2016.04.038. Epub 2016 Apr 27.
5
A High-Performance Liquid Chromatography Method for Determination of Genotoxic Impurity Hydroxylamine in Drug Substances.一种用于测定原料药中基因毒性杂质羟胺的高效液相色谱法。
J Chromatogr Sci. 2019 Jan 1;57(1):63-70. doi: 10.1093/chromsci/bmy082.
6
A Validated RP-HPLC Method for the Analysis of 1-Fluoronaphthalene and Its Process-Related Impurities.一种用于分析1-氟萘及其工艺相关杂质的经过验证的反相高效液相色谱法。
J Chromatogr Sci. 2015 Sep;53(8):1296-302. doi: 10.1093/chromsci/bmv006. Epub 2015 Feb 23.
7
Development of chromatographic methods for the determination of genotoxic impurities in cloperastine fendizoate.开发测定氯苯哌酯中遗传毒性杂质的色谱方法。
J Pharm Biomed Anal. 2012 Mar 5;61:230-6. doi: 10.1016/j.jpba.2011.12.014. Epub 2011 Dec 19.
8
Efficient UPLC and CE methods for the simultaneous determination of azelastine hydrochloride and its genotoxic impurity.高效超高效液相色谱法和毛细管电泳法同时测定盐酸氮卓斯汀及其遗传毒性杂质
Biomed Chromatogr. 2018 Nov;32(11):e4346. doi: 10.1002/bmc.4346. Epub 2018 Aug 20.
9
Determination of Bortezomib in API Samples Using HPLC: Assessment of Enantiomeric and Diastereomeric Impurities.使用高效液相色谱法测定原料药样品中的硼替佐米:对映体和非对映体杂质的评估
J Chromatogr Sci. 2017 Aug 1;55(7):697-705. doi: 10.1093/chromsci/bmx023.
10
Chromatographic Methods for Quantitative Determination of Ampicillin, Dicloxacillin and Their Impurity 6-Aminopenicillanic Acid.用于定量测定氨苄西林、双氯西林及其杂质6-氨基青霉烷酸的色谱方法。
J Chromatogr Sci. 2018 Mar 1;56(3):209-215. doi: 10.1093/chromsci/bmx101.

引用本文的文献

1
Development and validation of a method for quantitative determination of the genotoxic impurity diethyl sulfate in pitolisant hydrochloride high-performance liquid chromatography.盐酸匹莫林中遗传毒性杂质硫酸二乙酯定量测定方法的建立与验证——高效液相色谱法
RSC Adv. 2025 May 14;15(20):16125-16133. doi: 10.1039/d5ra01217a. eCollection 2025 May 12.
2
Eco-Friendly High-Performance Thin-Layer Chromatography Method for the Determination of Tenoxicam in Commercial Formulations.用于测定市售制剂中替诺昔康的环保型高效薄层色谱法
ACS Omega. 2023 Oct 12;8(42):39936-39944. doi: 10.1021/acsomega.3c07252. eCollection 2023 Oct 24.